Kunitoh H, Saijo N, Nagao K, Ohashi Y, Niitani H. Cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) in advanced (stager IIIB and stage IV) non-small cell lung cancer (NSCLC). A multicenter phase III study. Eur J Cancer 1999; 35(suppl 4):S249....
机译:我们在CDDP血药浓度测量下对患有肝转移的胃癌(CT2N1P0H1M0)血液透析(HD)患者进行了CPT-11 + CDDP治疗。 CPT-11在第1天和第14天输注90分钟,而CDDP在第1天输注2小时,每个疗程持续4周。透析日为星期一和星期五,星期五为第一天。在CDDP血药浓度测量的第一个过程中,显示出抗肿瘤作用的游离铂(...
PURPOSE: CPT-11 (60 mg/m2 on days 1, 8 and 15) in combination with CDDP (80 mg/m2 on day 1) has shown promising antitumor activity for non-small-cell lung cancer (NSCLC), but dose-limiting toxicities (DLT) are leukopenia and diarrhea, with a wide variation among patients. To estima...
Cetuximab (C225) Plus Cisplatin (CDDP) Irinotecan (CPT11) and Thoracic Radiotherapy (TRT) Definitive Treatment for Locally-advanced, Clinically Unresectable Esophageal Cancer: A Southwest Oncology Group (SWOG) Phase II Trial with Molecular Correlates (S0414) ...
We report three successful cases with irinotecan (CPT-11 60 mg/m2) + cisplatin (CDDP 30mg/m2) chemotherapy (once in 2 weeks) where S-1 failed to respond to recurrent gastric cancer. Case 1: A total gastrectomy and splenectomy were performed for a cardiac gastric cancer (T3, N2, H0, ...
We examined the efficacy and safety of neoadjuvant chemotherapy (NAC) with the CPT-11 + CDDP regimen in combination with radical hysterectomy.Shoji, TadahiroTakatori, ErikoFurutake, YokoTakada, AnnaNagasawa, TakayukiOmi, HideoKagabu, MasahiroHonda, TatsuyaMiura, FumiharuTakeuchi, SatoshiKumagai, Se...
Impact of irinotecan (CPT-11) and cisplatin (CDDP) on survival in previously untreated metastatic non-small cell lung cancer (NSCLC) [abstract]. Proc Am Soc Clin Oncol 2000; 19:495aFukuoka M, Nagao K, Ohashi Y, Niitani H (2000) Impact of irinotecan (CPT-11) and cisplatin (CDDP) on...
第23回日本肺癌学会北海道支部会 : 3.再発小細胞肺癌に対するCIC療法(CDDP+IFX+CPT-11+G-CSF)の検討 藤田,昭久,小島,弘,干野,英明,... - 《Japanese Journal of Lung Cancer》 被引量: 0发表: 1997年 PGE 1持続肝動注が有効であった急性膵炎後の肝細胞癌合併高度黄疸患者の1例 症例は65歳,男性...
Lung CancerSomer R, Langer C, Movsas B, et al. Phase I Study of Irinotecan (CPT-11), cisplatin (cDDP) and radical thoracic radiation (TRT) in the treatment of locally advanced non-small cell lung carcinoma (NSCLC). Pro Am Soc Clin Oncol. 21: 322a (A-1287), 2002....
Kinoshita A, Fukuda M, Kuba M, et al: Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) with concurrent thoracic radiotherapy (TRT) in limited-stage small-cell lung cancer (LS-SCLC) (abstract 1999). Proc Am Soc Clin Oncol 19:511a, 2000....